Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Expert consensus document : Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). / Banales, Jesus M; Cardinale, Vincenzo; Carpino, Guido; Marzioni, Marco; Andersen, Jesper B; Invernizzi, Pietro; Lind, Guro E; Folseraas, Trine; Forbes, Stuart J; Fouassier, Laura; Geier, Andreas; Calvisi, Diego F; Mertens, Joachim C; Trauner, Michael; Benedetti, Antonio; Maroni, Luca; Vaquero, Javier; Macias, Rocio I R; Raggi, Chiara; Perugorria, Maria J; Gaudio, Eugenio; Boberg, Kirsten M; Marin, Jose J G; Alvaro, Domenico.
I: Nature Reviews. Gastroenterology & Hepatology, Bind 13, Nr. 5, 05.2016, s. 261-280.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Expert consensus document
T2 - Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
AU - Banales, Jesus M
AU - Cardinale, Vincenzo
AU - Carpino, Guido
AU - Marzioni, Marco
AU - Andersen, Jesper B
AU - Invernizzi, Pietro
AU - Lind, Guro E
AU - Folseraas, Trine
AU - Forbes, Stuart J
AU - Fouassier, Laura
AU - Geier, Andreas
AU - Calvisi, Diego F
AU - Mertens, Joachim C
AU - Trauner, Michael
AU - Benedetti, Antonio
AU - Maroni, Luca
AU - Vaquero, Javier
AU - Macias, Rocio I R
AU - Raggi, Chiara
AU - Perugorria, Maria J
AU - Gaudio, Eugenio
AU - Boberg, Kirsten M
AU - Marin, Jose J G
AU - Alvaro, Domenico
PY - 2016/5
Y1 - 2016/5
N2 - Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies with features of biliary tract differentiation. CCA is the second most common primary liver tumour and the incidence is increasing worldwide. CCA has high mortality owing to its aggressiveness, late diagnosis and refractory nature. In May 2015, the [ldquo]European Network for the Study of Cholangiocarcinoma[rdquo] (ENS-CCA: www.enscca.org or www.cholangiocarcinoma.eu) was created to promote and boost international research collaboration on the study of CCA at basic, translational and clinical level. In this Consensus Statement, we aim to provide valuable information on classifications, pathological features, risk factors, cells of origin, genetic and epigenetic modifications and current therapies available for this cancer. Moreover, future directions on basic and clinical investigations and plans for the ENS-CCA are highlighted.
AB - Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies with features of biliary tract differentiation. CCA is the second most common primary liver tumour and the incidence is increasing worldwide. CCA has high mortality owing to its aggressiveness, late diagnosis and refractory nature. In May 2015, the [ldquo]European Network for the Study of Cholangiocarcinoma[rdquo] (ENS-CCA: www.enscca.org or www.cholangiocarcinoma.eu) was created to promote and boost international research collaboration on the study of CCA at basic, translational and clinical level. In this Consensus Statement, we aim to provide valuable information on classifications, pathological features, risk factors, cells of origin, genetic and epigenetic modifications and current therapies available for this cancer. Moreover, future directions on basic and clinical investigations and plans for the ENS-CCA are highlighted.
U2 - 10.1038/nrgastro.2016.51
DO - 10.1038/nrgastro.2016.51
M3 - Journal article
VL - 13
SP - 261
EP - 280
JO - Nature Reviews. Gastroenterology & Hepatology
JF - Nature Reviews. Gastroenterology & Hepatology
SN - 1759-5045
IS - 5
ER -
ID: 192292024